Sentinel Node in Colon Cancer

Sentinel Node Study in Colon Cancer Surgery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00411112

Enrollment

140

Registered

2006-12-13

Start date

2007-03-31

Completion date

Unknown

Last updated

2009-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Keywords

Sentinel node, Isosulphan blue, Isotopic detection, Survival

Brief summary

More than 20% of patients operated on for colon cancer without node metastasis will develop visceral metastases. The purpose of the study is to determine sentinel lymph nodes with two methods: blue injection and isotopic detection. Sentinel nodes will then be analyzed by immunohistochemy to detect micrometastases. No adjuvant therapy will be proposed to the patient if there are only node's micrometastases and survival will be analyzed in regard to the presence of these micrometastasis.

Interventions

PROCEDUREblue and isotopic detection of sentinel lymph nodes

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* adult * colon cancer * open surgery

Exclusion criteria

* emergency surgery * metastases

Design outcomes

Primary

Measure	Time frame
Survival without recurrence after 3 years	—

Countries

France

Contacts

Primary ContactCécile Brigand, MD

cecile.brigand@chru-strasbourg.fr3 33 88 12 72 36

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026